← FDA DRUG APPROVALS

FDA ANDA · ANDA087908

HYDRALAZINE HYDROCHLORIDE

Sponsor: VANGARD

APPLICATION
ANDA087908
TYPE
ANDA
ORIGINAL APPROVAL
1982-05-07
LATEST ACTION
1987-10-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDRALAZINE HYDROCHLORIDEDiscontinued
HYDRALAZINE HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

1987-10-20Manufacturing (CMC) · Supplement 9AP
1983-10-26Manufacturing (CMC) · Supplement 4AP
1983-10-26Manufacturing (CMC) · Supplement 5AP
1983-07-06Manufacturing (CMC) · Supplement 2AP
1982-05-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →